CMV VIREMIA
Clinical trials for CMV VIREMIA explained in plain language.
Never miss a new study
Get alerted when new CMV VIREMIA trials appear
Sign up with your email to follow new studies for CMV VIREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Virus-Fighting drug shrink brain tumors in breast cancer patients?
Disease control Recruiting nowThis study tests whether adding an anti-CMV medication (valganciclovir) to standard care can shrink brain tumors in breast cancer patients whose disease has spread to the brain and who also have a CMV infection. About 28 adults with progressive brain metastases and evidence of CM…
Matched conditions: CMV VIREMIA
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
Heart transplant study tests safer CMV prevention
Prevention Recruiting nowThis study compares two drugs, letermovir and valganciclovir, to see which is safer and more effective at preventing CMV infection in heart transplant patients at moderate to high risk. About 150 adults who have recently received a heart transplant will take one of the two medica…
Matched conditions: CMV VIREMIA
Phase: PHASE2, PHASE3 • Sponsor: Columbia University • Aim: Prevention
Last updated May 11, 2026 20:40 UTC